150 related articles for article (PubMed ID: 8577701)
1. Properties of a single-chain antibody containing different linker peptides.
Alfthan K; Takkinen K; Sizmann D; Söderlund H; Teeri TT
Protein Eng; 1995 Jul; 8(7):725-31. PubMed ID: 8577701
[TBL] [Abstract][Full Text] [Related]
2. "Diabodies": small bivalent and bispecific antibody fragments.
Holliger P; Prospero T; Winter G
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6444-8. PubMed ID: 8341653
[TBL] [Abstract][Full Text] [Related]
3. An active single-chain antibody containing a cellulase linker domain is secreted by Escherichia coli.
Takkinen K; Laukkanen ML; Sizmann D; Alfthan K; Immonen T; Vanne L; Kaartinen M; Knowles JK; Teeri TT
Protein Eng; 1991 Oct; 4(7):837-41. PubMed ID: 1798707
[TBL] [Abstract][Full Text] [Related]
4. Lipid-tagged antibodies: bacterial expression and characterization of a lipoprotein-single-chain antibody fusion protein.
Laukkanen ML; Teeri TT; Keinänen K
Protein Eng; 1993 Jun; 6(4):449-54. PubMed ID: 8332603
[TBL] [Abstract][Full Text] [Related]
5. Use of 2D NMR, protein engineering, and molecular modeling to study the hapten-binding site of an antibody Fv fragment against 2-phenyloxazolone.
McManus S; Riechmann L
Biochemistry; 1991 Jun; 30(24):5851-7. PubMed ID: 2043627
[TBL] [Abstract][Full Text] [Related]
6. Single-chain Fv of anti-idiotype 11-1G10 antibody interacts with antibody NC41 single-chain Fv with a higher affinity than the affinity for the interaction of the parent Fab fragments.
Iliades P; Dougan DA; Oddie GW; Metzger DW; Hudson PJ; Kortt AA
J Protein Chem; 1998 Apr; 17(3):245-54. PubMed ID: 9588948
[TBL] [Abstract][Full Text] [Related]
7. Multimerization of a chimeric anti-CD20 single-chain Fv-Fc fusion protein is mediated through variable domain exchange.
Wu AM; Tan GJ; Sherman MA; Clarke P; Olafsen T; Forman SJ; Raubitschek AA
Protein Eng; 2001 Dec; 14(12):1025-33. PubMed ID: 11809933
[TBL] [Abstract][Full Text] [Related]
8. Functional construction of the anti-mucin core protein (MUC1) antibody MUSE11 variable regions in a bacterial expression system.
Asano R; Takemura S; Tsumoto K; Sakurai N; Teramae A; Ebara S; Katayose Y; Shinoda M; Suzuki M; Imai K; Matsuno S; Kudo T; Kumagai I
J Biochem; 2000 Apr; 127(4):673-9. PubMed ID: 10739961
[TBL] [Abstract][Full Text] [Related]
9. Colony assays for antibody fragments expressed in bacteria.
Dreher ML; Gherardi E; Skerra A; Milstein C
J Immunol Methods; 1991 Jun; 139(2):197-205. PubMed ID: 2045660
[TBL] [Abstract][Full Text] [Related]
10. scFv multimers of the anti-neuraminidase antibody NC10: length of the linker between VH and VL domains dictates precisely the transition between diabodies and triabodies.
Atwell JL; Breheney KA; Lawrence LJ; McCoy AJ; Kortt AA; Hudson PJ
Protein Eng; 1999 Jul; 12(7):597-604. PubMed ID: 10436086
[TBL] [Abstract][Full Text] [Related]
11. Phage display and selection of a site-directed randomized single-chain antibody Fv fragment for its affinity improvement.
Riechmann L; Weill M
Biochemistry; 1993 Aug; 32(34):8848-55. PubMed ID: 8364031
[TBL] [Abstract][Full Text] [Related]
12. Generation of a single-chain Fv fragment for the monitoring of deoxycholic acid residues anchored on endogenous proteins.
Kobayashi N; Ohtoyo M; Wada E; Kato Y; Mano N; Goto J
Steroids; 2005 Apr; 70(4):285-94. PubMed ID: 15784283
[TBL] [Abstract][Full Text] [Related]
13. Effect of linker flexibility and length on the functionality of a cytotoxic engineered antibody fragment.
Klement M; Liu C; Loo BL; Choo AB; Ow DS; Lee DY
J Biotechnol; 2015 Apr; 199():90-7. PubMed ID: 25697559
[TBL] [Abstract][Full Text] [Related]
14. Characterization of scFv-Ig constructs generated from the anti-CD20 mAb 1F5 using linker peptides of varying lengths.
Shan D; Press OW; Tsu TT; Hayden MS; Ledbetter JA
J Immunol; 1999 Jun; 162(11):6589-95. PubMed ID: 10352275
[TBL] [Abstract][Full Text] [Related]
15. Variable region sequence modulates periplasmic export of a single-chain Fv antibody fragment in Escherichia coli.
Ayala M; Balint RF; Fernández-de-Cossío L; Canaán-Haden JW; Larrick JW; Gavilondo JV
Biotechniques; 1995 May; 18(5):832, 835-8, 840-2. PubMed ID: 7619489
[TBL] [Abstract][Full Text] [Related]
16. Conformational stability, folding, and ligand-binding affinity of single-chain Fv immunoglobulin fragments expressed in Escherichia coli.
Pantoliano MW; Bird RE; Johnson S; Asel ED; Dodd SW; Wood JF; Hardman KD
Biochemistry; 1991 Oct; 30(42):10117-25. PubMed ID: 1931943
[TBL] [Abstract][Full Text] [Related]
17. Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer.
Kortt AA; Lah M; Oddie GW; Gruen CL; Burns JE; Pearce LA; Atwell JL; McCoy AJ; Howlett GJ; Metzger DW; Webster RG; Hudson PJ
Protein Eng; 1997 Apr; 10(4):423-33. PubMed ID: 9194168
[TBL] [Abstract][Full Text] [Related]
18. Molecular modelling study of antigen binding to oxazolone-specific antibodies: the Ox1 idiotypic IgG and its mature variant with increased affinity to 2-phenyloxazolone.
Holm L; Laaksonen L; Kaartinen M; Teeri TT; Knowles JK
Protein Eng; 1990 Apr; 3(5):403-9. PubMed ID: 2349210
[TBL] [Abstract][Full Text] [Related]
19. Construction of multiform scFv antibodies using linker peptide.
Wang S; Zheng C; Liu Y; Zheng H; Wang Z
J Genet Genomics; 2008 May; 35(5):313-6. PubMed ID: 18499076
[TBL] [Abstract][Full Text] [Related]
20. Bacterial single-chain antibody fragments, specific for carcinoembryonic antigen.
Ayala M; Dueñas M; Santos A; Vázquez J; Menéndez A; Silva A; Gavilondo JV
Biotechniques; 1992 Nov; 13(5):790-9. PubMed ID: 1418981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
